Eli Lilly and Company

Associate Director - Global Marketing Preclinical Diagnostics Strategy

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree and have a minimum of 5 years of marketing experience. Experience in cross-functional leadership, new product launches, strategic development, OUS and/or IBU experience, and launch experience in AD and/or diagnostics are preferred. A background in Pharmaceutical or Diagnostics is also desired, along with strong critical thinking, teamwork, leadership in ambiguity, curiosity, agility, an innovative demeanor, excellent communication, negotiation, and influencing skills, and the ability to prioritize and drive decision-making in dynamic environments. Applicants must be authorized to work in the United States on a full-time basis.

Responsibilities

The Associate Director will lead commercial initiatives to shape the external diagnostic landscape for preclinical Alzheimer’s Disease (AD), ensuring accurate diagnosis and supporting asset launches. They will run core workstreams to develop infrastructure and guide strategy for improving access to blood-based diagnostics and build external partnerships. Responsibilities include leading governance for diagnostics roadmaps, developing integrated go-to-market commercial strategies, collaborating across departments to align diagnostics with the platform strategy, and contributing to internal strategic governance. The role involves assessing and shaping market readiness for diagnostics and therapeutics, guiding prioritized geographies in building diagnostic strategies, and collaborating to address environmental barriers. Additionally, the Associate Director will monitor the diagnostic environment, provide insights and recommendations, support diagnostics manufacturer partnerships, lead global diagnostics commercialization strategy, and support affiliate execution and acceleration of diagnostic adoption.

Skills

Marketing Strategy
Diagnostics
Alzheimer's Disease
Commercial Strategy
Market Access
Reimbursement
Advocacy Engagement
Go-to-Market Strategy
Partnership Building
Strategic Planning
Business Planning
Launch Readiness
Brand Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI